Niagen Bioscience Inc (NAGE) Free Cash Flow
Niagen Bioscience Inc (NAGE) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$4.66M |
| 2017-12-31 | -$5.20M |
| 2018-12-31 | -$22.36M |
| 2019-12-31 | -$20.45M |
| 2020-12-31 | -$10.62M |
| 2021-12-31 | -$24.57M |
| 2022-12-31 | -$15.43M |
| 2023-12-31 | $6.97M |
| 2024-12-31 | $12.11M |
| 2025-12-31 | $13.50M |
How NAGE compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| NRC | National Research Corporation | $15.74M |
| ETON | Eton Pharmaceuticals Inc. | $10.19M |
| TXMD | TherapeuticsMD Inc. | $2.45M |
| CERS | Cerus Corporation | $1.11M |
| RMTI | Rockwell Medical Inc. | -$1.24M |
These are five companies in the same sector as NAGE with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Niagen Bioscience Inc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("NAGE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NAGE | $3.17 | +1.93% | 0.26M |
| 3 | ||||
| 4 | ||||
| 5 |